• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Outset Medical to Report Fourth Quarter and Full Year 2022 Financial Results on Monday, February 13, 2023

By: Outset Medical, Inc. via Business Wire
January 25, 2023 at 08:30 AM EST

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full year of 2022 after the close of trading on Monday, February 13, 2023.

On the same day, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) Leslie Trigg, Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Monday, February 13, 2023. Those interested in listening to the conference call may do so by registering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230125005011/en/

Contacts

Jim Mazzola

Vice President, Investor Relations

jmazzola@outsetmedical.com

Brian Johnston

Gilmartin Group

investors@outsetmedical.com

More News

View More
Should Investors Lock Arms With Buffett and Dive Into POOL Stock?
July 29, 2025
Via MarketBeat
Topics Artificial Intelligence Regulatory Compliance
Tickers BRK-A BRK-B ORCL POOL
Big 3 Telecom Wars: 2 Solid Showings, 1 Huge Winner in Q2
July 29, 2025
Via MarketBeat
Tickers MS T TMUS VZ
Analysts Are Upgrading These 3 Massive AI Stocks After Earnings
July 29, 2025
Via MarketBeat
Topics Artificial Intelligence
Tickers GEV GOOGL NOW
Act Fast: These 3 Undervalued Stocks Won’t Stay Low for Long
July 29, 2025
Via MarketBeat
Tickers ALB INTC XPEV
Top 220 Most Beloved Local Businesses Across the U.S. [2025 Survey]
July 29, 2025
Via MarketBeat
Topics Economy
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap